Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10253-1 | Glycyl-H-1152 | LSM-4274 | |||
10245-1 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 | ||
10279-1 | Trichostatin A | LSM-43005 | |||
10262-1 | L-779450 | LSM-4283 | 9950176 | ||
10514-1 | PS-1145 | 9949093 | |||
10096-2 | ZM-447439 | LSM-1096 | 9914412 | ||
10136-2 | TPCA-1 | LSM-1136 | 9903786 | ||
10274-1 | SB-3CT | LSM-4293 | 9883002 | ||
10348-1 | Z-Leu-Leu-Norvalinal | MG-115 | LSM-6358 | 9868928 | |
10228-2 | IKK16 | LSM-2309 | 9549298 | ||
10208-2 | JNK-IN-5A | TCS JNK 5a; KIN001-188 | LSM-1209 | 766949 | |
10251-1 | Fascaplysin | LSM-4272 | 73293 | ||
10048-7 | PD184352 | CI-1040 | LSM-1048 | 6918454 | |
10048-6 | PD184352 | CI-1040 | LSM-1048 | 6918454 | |
10048 | PD184352 | CI-1040 | LSM-1048 | 6918454 | |
10257-1 | GSK923295 | LSM-4278 | 68651179 | ||
10260-1 | Ispinesib | SB-715992 | LSM-5732 | 6851740 | |
10280-1 | Triciribine | LSM-3810 | 65399 | ||
10108-2 | Geldanamycin | LSM-42789 | 644250 | ||
10099-2 | Nilotinib | AMN-107 | LSM-1099 | 644241 | |
10513-1 | Nelfinavir | Viracept | 64143 | ||
10246-1 | CPT-11 | Irinotecan | LSM-2167 | 60838 | |
10252-1 | Gemcitabine | Gemzar | LSM-5333 | 60750 | |
10278-1 | Topotecan | Hycamtin | LSM-5662 | 60700 | |
10133-2 | Afatinib | BIBW-2992 | LSM-43226 | 57519523 |